1. Home
  2. ANAB vs ASAN Comparison

ANAB vs ASAN Comparison

Compare ANAB & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$56.36

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Asana Inc.

ASAN

Asana Inc.

N/A

Current Price

$8.77

Market Cap

1.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ANAB
ASAN
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ANAB
ASAN
Price
$56.36
$8.77
Analyst Decision
Buy
Hold
Analyst Count
12
14
Target Price
$71.67
$12.46
AVG Volume (30 Days)
346.5K
4.2M
Earning Date
05-08-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
27.93
EPS
N/A
N/A
Revenue
$234,603,000.00
$790,806,000.00
Revenue This Year
N/A
$10.19
Revenue Next Year
$52.14
$7.91
P/E Ratio
N/A
N/A
Revenue Growth
157.01
9.25
52 Week Low
$17.11
$5.38
52 Week High
$73.30
$15.48

Technical Indicators

Market Signals
Indicator
ANAB
ASAN
Relative Strength Index (RSI) 49.46 61.91
Support Level $53.46 $8.86
Resistance Level $57.70 $15.28
Average True Range (ATR) 2.33 0.44
MACD -0.15 -0.02
Stochastic Oscillator 38.76 75.49

Price Performance

Historical Comparison
ANAB
ASAN

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About ASAN Asana Inc.

Asana Inc is the system of action for work, built for the Agentic Enterprise. It provides a comprehensive solution where humans and AI agents can collaborate effectively so that individuals work smarter, teams move faster, and organizations deliver results. Companies use Asana to connect their work to company goals and orchestrate mission-critical workflows like product launches, employee onboarding, resource planning, tracking company-wide strategic initiatives and more. It manages its operations and allocates resources as a single operating and reportable segment. The company generates revenues from subscriptions from paying customers accessing its cloud-based platform.

Share on Social Networks: